
VACCITECH (SP.ADR)/1
Depository Receipt · US91864C1071 · BRNS · A3CN5Q (XNMS)
0,88 EUR
10.06.2025 19:54
Current Prices from VACCITECH (SP.ADR)/1
Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
---|---|---|---|---|---|
![]() NASDAQ |
BRNS
|
USD
|
10.06.2025 19:54
|
1,00 USD
| 0,99 USD
+0,97 %
|
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | -0,83 % | 9,16 % | -0,55 % | -2,30 % | -50,55 % | -92,99 % |
Company Profile for VACCITECH (SP.ADR)/1 Depository Receipt
Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B infection; VTP-200 that is in Phase 1/2a clinical trial for the treatment of human papilloma virus infection; VTP-850, which is in Phase 1/2 clinical trial for the treatment of prostate cancer; and VTP-600 that is in Phase 1/2a clinical trial for the treatment of non-small cell lung cancer. Its prophylactic programs include VTP-400, which is in preclinical stage for the prevention of herpes zoster or shingles; VTP-500 that has completed Phase 1 clinical trial for the prevention of Middle East respiratory syndrome; and Vaxzevria, a prophylactic vaccine for the prevention of COVID-19 infection. The company was formerly known as Vaccitech Rx Limited and changed its name to Vaccitech plc in March 2021. Vaccitech plc was founded in 2016 and is headquartered in Oxford, the United Kingdom.
Company Data
Name VACCITECH (SP.ADR)/1
Company Vaccitech plc
Symbol BRNS
Website
https://www.vaccitech.co.uk
Primary Exchange
Frankfurt

WKN A3CN5Q
ISIN US91864C1071
Asset Class Depository Receipt
Sector Healthcare
Industry Biotechnology
CEO Mr. William J. Enright MBA
Market Capitalization 193 Mio
Country United Kingdom
Currency EUR
Employees 0,0 T
Address The SchrOedinger Building, OX4 4GE Oxford
IPO Date 2021-04-30
ID Changes
Date | From | To |
---|---|---|
07.11.2023 | VACC | BRNS |
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | 2AB.F |
NASDAQ | BRNS |
NASDAQ | VACC |
More Shares
Investors who VACCITECH (SP.ADR)/1 hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.